MEDICE Arzneimittel Pütter GmbH & Co. KG.
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1949-01-01
- Employees
- 501
- Market Cap
- -
- Website
- https://medice.com/de-de
A Study to See if a Combination of Vitamins That is Injected Into a Muscle is as Good and Safe as a Vitamin That is Taken by Mouth
- Conditions
- Vitamin B12 Deficiency
- Interventions
- Drug: Vitamin B12, Vitamin B6, Folic acidDrug: Vitamin B12 (Cyanocobalamin)
- First Posted Date
- 2025-06-19
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- Medice Arzneimittel Pütter GmbH & Co KG
- Target Recruit Count
- 46
- Registration Number
- NCT07029698
- Locations
- 🇺🇦
State institution "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv, Ukraine
🇺🇦Private Enterprise Private Manufacturing Company "Acinus", Kropyvnytskyi, Ukraine
Efficacy and Safety of Alflorex Bei Reizdarm in Patients With Irritable Bowel Syndrome
- Conditions
- Irritable Bowel Syndrome
- First Posted Date
- 2021-04-26
- Last Posted Date
- 2022-01-06
- Lead Sponsor
- Medice Arzneimittel Pütter GmbH & Co KG
- Target Recruit Count
- 37
- Registration Number
- NCT04859075
- Locations
- 🇩🇪
Several General Practicioner and Gastroenterologists (Multicentric), Düsseldorf, Nordrhein-Westfalen, Germany
Efficacy and Tolerability of a Phytotherapy Combination (Aqualibra) in Patients With Uncomplicated Cystitis
- Conditions
- Urinary Tract Infection Lower Acute
- Interventions
- Combination Product: Herbal Medicinal ProductOther: Placebo
- First Posted Date
- 2019-07-25
- Last Posted Date
- 2019-07-26
- Lead Sponsor
- Medice Arzneimittel Pütter GmbH & Co KG
- Target Recruit Count
- 200
- Registration Number
- NCT04032574
Safety and Efficacy of a Sore Throat Lozenge DORITHRICIN in Patients With Acute Pharyngitis
- Conditions
- Pharyngitis
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2017-10-27
- Last Posted Date
- 2017-11-28
- Lead Sponsor
- Medice Arzneimittel Pütter GmbH & Co KG
- Target Recruit Count
- 321
- Registration Number
- NCT03323528
- Locations
- 🇩🇪
doc-HNO for the DoriPha investigators, Röthenbach an der Pegnitz, Germany
Attentin® in Children and Adolescents With ADHD - A Non-interventional Study
- Conditions
- Attention Deficit Hyperactivity Disorder
- First Posted Date
- 2016-06-16
- Last Posted Date
- 2020-09-02
- Lead Sponsor
- Medice Arzneimittel Pütter GmbH & Co KG
- Target Recruit Count
- 150
- Registration Number
- NCT02801604
- Locations
- 🇩🇪
Child and Adolescent Psychiatry, University of Medicine, Mainz, Germany
Integrated Diagnosis and Treatment of Adults With Attention-deficit/Hyperactivity Disorder
- Conditions
- Adult Attention-deficit/Hyperactivity Disorder
- First Posted Date
- 2012-06-08
- Last Posted Date
- 2015-04-15
- Lead Sponsor
- Medice Arzneimittel Pütter GmbH & Co KG
- Target Recruit Count
- 468
- Registration Number
- NCT01615679
- Locations
- 🇩🇪
Universität des Saarlandes, Gerichtliche Psychologie und Psychiatrie, Homburg, Germany
Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
- Conditions
- Chronic Kidney DiseaseHemodialysisHyperphosphatemia
- Interventions
- First Posted Date
- 2010-09-14
- Last Posted Date
- 2012-01-18
- Lead Sponsor
- Medice Arzneimittel Pütter GmbH & Co KG
- Target Recruit Count
- 252
- Registration Number
- NCT01200784
Methylphenidate Treatment of Cancer-Related Fatigue
- Conditions
- Cancer-related Fatigue
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2010-01-13
- Lead Sponsor
- Medice Arzneimittel Pütter GmbH & Co KG
- Target Recruit Count
- 66
- Registration Number
- NCT00758407
- Locations
- 🇩🇪
Sonnenbergklinik, Bad Sooden-Allendorf, Germany
🇩🇪Praxis Dr. Lathan, Dortmund, Germany
🇩🇪Praxis Dr. Verpoort - Dr. Zeller, Hamburg, Germany
Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA
- Conditions
- Attention Deficit Hyperactivity Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2010-01-13
- Lead Sponsor
- Medice Arzneimittel Pütter GmbH & Co KG
- Target Recruit Count
- 150
- Registration Number
- NCT00730249
- Locations
- 🇩🇪
Praxis Johannes Fuhr, Bad Wildungen, Germany
🇩🇪Charité Campus Mitte, Station 155, Berlin, Germany
🇩🇪Gemeinschaftspraxis für Kinder- und Jugendpsychiatrie, Psychotherapie, Berlin, Germany
Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD
- Conditions
- Attention Deficit Hyperactivity Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-02-21
- Last Posted Date
- 2008-02-21
- Lead Sponsor
- Medice Arzneimittel Pütter GmbH & Co KG
- Target Recruit Count
- 363
- Registration Number
- NCT00619840
- Locations
- 🇩🇪
Institute of Forensic Psychology and Psychiatry, Homburg/Saar, Sarland, Germany